Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DPN1F0
|
|||
| Drug Name |
ADXS-503
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 1/2 | [1] | |
| Company |
Advaxis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03847519) Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.